Cerity Partners LLC Trims Position in iShares Biotechnology ETF (NASDAQ:IBB)

Cerity Partners LLC lessened its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.7% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 49,067 shares of the financial services provider’s stock after selling 1,887 shares during the quarter. Cerity Partners LLC owned 0.11% of iShares Biotechnology ETF worth $6,276,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of IBB. Proficio Capital Partners LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth about $480,000. FineMark National Bank & Trust purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth about $319,000. Kingswood Wealth Advisors LLC increased its position in iShares Biotechnology ETF by 81.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 4,532 shares of the financial services provider’s stock worth $570,000 after buying an additional 2,031 shares in the last quarter. Destiny Wealth Partners LLC increased its position in iShares Biotechnology ETF by 6.7% in the first quarter. Destiny Wealth Partners LLC now owns 69,865 shares of the financial services provider’s stock worth $8,936,000 after buying an additional 4,358 shares in the last quarter. Finally, Modern Wealth Management LLC purchased a new stake in iShares Biotechnology ETF in the fourth quarter worth about $237,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $129.05 on Wednesday. The business has a 50-day simple moving average of $125.34 and a two-hundred day simple moving average of $129.00. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $150.57.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.